封面
市場調查報告書
商品編碼
1917782

消毒劑和清潔劑市場-2026-2031年預測

Antiseptic and Disinfectant Market - Forecast from 2026 to 2031

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計消毒劑和清潔劑市場將從 2025 年的 414.63 億美元成長到 2031 年的 583.8 億美元,複合年成長率為 5.87%。

消毒劑和清潔劑市場正經歷強勁成長,這主要得益於醫療機構對酒精類消毒劑需求的不斷成長。醫療機構正在加強消毒劑的使用力度,以遏制醫院感染(HAI)。製造商正投入大量研發資源,開發先進的頻譜消毒解決方案。保險公司擴大報銷範圍的政策也使全球消毒劑的普及程度不斷提高。

消毒劑的作用機轉和應用範圍與抗生素不同,可提供頻譜抗菌活性,適用於局部和表面處理。儘管目前證據有限,但消毒劑的廣泛使用引發了關於微生物抗藥性潛在風險的持續爭論。預防感染的需求、監管機構對衛生問題的重視以及製劑功效的創新推動了市場的穩定成長。

感染發生率的上升是成長要素,因此需要在各個層面採取強力的預防措施。由於衛生和預防措施不力,院內感染(HAI)的增加凸顯了消毒劑和清潔劑在污染控制和減少感染傳播方面的重要性。優惠的報銷方案正在刺激先進產品的採用,使其價格更加親民,即使在經濟條件有限的情況下也能負擔得起。表面消毒劑,例如次氯酸鈉和高濃度酒精,在惰性環境消毒方面展現出顯著的潛力。醫療設備消毒劑利用過氧化氫、過氧乙酸和戊二醛等化合物,滿足內視鏡和手術器械的再處理需求。隨著手術數量的增加,它們有助於防止患者之間的交叉感染。由於酒精類產品能夠快速、無毒地殺死包括細菌、病毒和真菌在內的多種病原體,因此在器械消毒方面越來越受歡迎。

由於醫護人員數量不斷增加、外科手術量上升以及醫院感染(HAI)的普遍存在,預計北美將引領市場。該地區對感染治療的重視和嚴格的衛生通訊協定正在推動市場需求。

總體而言,市場正經歷強勁成長,這得益於感染控制的優先事項、報銷支援以及表面、設備和酒精類解決方案等細分領域的進步,從而使消毒劑和清潔劑成為安全臨床實踐和公共衛生韌性的基礎要素。

本報告的主要優勢:

  • 深入分析:提供對主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局:了解全球主要參與者的策略舉措,並了解透過正確的策略進入市場的機會。
  • 市場促進因素與未來趨勢:探索市場促進因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議:利用這些見解,在快速變化的環境中做出策略決策,並發現新的商機和收入來源。
  • 受眾廣泛:適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業,且經濟實惠。

企業如何使用我們的報告?

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

研究範圍:

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區(包括國家)分類的收入和預測評估
  • 公司概況(策略、產品、財務資訊、關鍵發展等)

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 按類型分類的消毒劑和清潔劑市場

  • 介紹
  • 季銨化合物
  • 氯基化合物
  • 醇和醛類產品
  • 酵素
  • 其他

6. 按產品分類的消毒劑和清潔劑市場

  • 介紹
  • 酵素性清潔劑
  • 醫療設備消毒劑
  • 表面消毒劑

7. 按最終用戶分類的消毒劑和清潔劑市場

  • 介紹
  • 醫院
  • 診所
  • 其他

8. 按地區分類的消毒劑和清潔劑市場

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章:公司簡介

  • PSK Pharma
  • ACTO GmbH
  • Dr. Schumacher GmbH
  • 3M
  • Reckitt Benckiser
  • Steris Plc
  • Kimberly-Clark Corporation
  • Cardinal Health
  • BD

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061615753

Antiseptic And Disinfectant Market, growing at a 5.87% CAGR, is expected to grow to USD 58.38 billion in 2031 from USD 41.463 billion in 2025.

The antiseptic and disinfectant market is witnessing strong growth, driven by heightened demand for alcohol-based disinfectants in clinical environments. Healthcare facilities are intensifying antiseptic usage to curb hospital-acquired infections (HAIs). Manufacturers are committing substantial R&D resources to formulate advanced, broad-spectrum solutions. Reimbursement policies from insurers are broadening access to disinfectant treatments worldwide.

Antiseptics and disinfectants provide broad-spectrum antimicrobial activity for topical and surface applications, distinct from antibiotics in mechanism and scope. Extensive use has sparked ongoing discussions regarding potential microbial resistance development, though evidence remains limited. The market is expanding steadily, supported by infection prevention imperatives, regulatory emphasis on hygiene, and innovation in formulation efficacy.

Key growth drivers include rising infection incidence, necessitating robust preventive measures across populations. Escalating HAIs, stemming from lapses in sanitation and precautions, underscore the critical role of antiseptics and disinfectants in contamination control and transmission reduction. Attractive reimbursement frameworks enhance affordability, encouraging adoption of advanced products despite economic constraints. Surface disinfectants demonstrate notable potential, employing agents like sodium hypochlorite and high-concentration alcohols for inert environment sanitization. Medical device disinfectants, utilizing compounds such as hydrogen peroxide, peracetic acid, and glutaraldehyde, address reprocessing needs for endoscopes and surgical tools to prevent cross-patient contamination amid increasing procedural volumes. Alcohol-based variants are gaining traction for instrument disinfection due to rapid, non-toxic action against diverse pathogens, including bacteria, viruses, and fungi.

Geographically, North America is anticipated to lead, fueled by expanding healthcare workforce, rising surgical volumes, and heightened HAI prevalence. The region's focus on infection therapies and stringent hygiene protocols amplifies demand.

Overall, the market is progressing robustly, anchored in infection control priorities, reimbursement support, and segment-specific advancements in surface, device, and alcohol-based solutions, positioning antiseptics and disinfectants as foundational to safe clinical practice and public health resilience.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Antiseptic and Disinfectant Market Segmentation

  • By Type
  • Quaternary Ammonium Compounds
  • Chlorine Compounds
  • Alcohols & Aldehyde Products
  • Enzyme
  • Others
  • By Product
  • Enzymatic Cleaners
  • Medical Device Disinfectants
  • Surface Disinfectants
  • By End-User
  • Hospitals
  • Clinics
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANTISEPTIC AND DISINFECTANT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Quaternary Ammonium Compounds
  • 5.3. Chlorine Compounds
  • 5.4. Alcohols & Aldehyde Products
  • 5.5. Enzyme
  • 5.6. Others

6. ANTISEPTIC AND DISINFECTANT MARKET BY PRODUCT

  • 6.1. Introduction
  • 6.2. Enzymatic Cleaners
  • 6.3. Medical Device Disinfectants
  • 6.4. Surface Disinfectants

7. ANTISEPTIC AND DISINFECTANT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Others

8. ANTISEPTIC AND DISINFECTANT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. PSK Pharma
  • 10.2. ACTO GmbH
  • 10.3. Dr. Schumacher GmbH
  • 10.4. 3M
  • 10.5. Reckitt Benckiser
  • 10.6. Steris Plc
  • 10.7. Kimberly-Clark Corporation
  • 10.8. Cardinal Health
  • 10.9. BD

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations